Evidence map›Paper›PMID 33743202›Full record

GuidelineAtencion primaria2021

[Checklist for patients with type 2 diabetes mellitus for remote consultation].

Escarlata Angullo-Martínez, Enrique Carretero-Anibarro, Ignacio Manuel Sánchez Barrancos, Xavier Cos Claramunt, Domingo Orozco Beltrán, José Luis Torres Baile, Patxi Ezkurra Loiola, en representación del Grupo de Trabajo de Diabetes de la SemFyC, en representación del Grupo de Trabajo de Diabetes de la SemFyC

Abstract readPractice Guideline
In one paragraph

Guideline in Atencion primaria, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Escarlata Angullo-MartínezMedicina Familiar y Comunitaria, Centro de salud Escola Graduada; Grupo de Trabajo de Diabetes de la semFyC, Palma (Islas Baleares), España. Electronic address: eangullo@ibsalut.caib.es.
Enrique Carretero-AnibarroMedicina Familiar y Comunitaria, Centro de salud Herrrera; Grupo de Trabajo de Diabetes de la semFyC, Sevilla, España.
Ignacio Manuel Sánchez BarrancosMedicina Familiar y Comunitaria, Consultorio de Membrilla, Centro de salud Manzanares 2; Grupo de Trabajo de Diabetes de la semFyC, Manzanares (Ciudad Real), España.
Xavier Cos ClaramuntMedicina Familiar y Comunitaria, Institut Català de la Salut; Grupo de Trabajo de Diabetes de la semFyC, Barcelona, España; Facultat de Medicina, Universitat Autonoma de Barcelona; IDIAP Jordi Gol; Grupo de Trabajo de Diabetes de la semFyC, Barcelona, España.
Domingo Orozco BeltránMedicina Familiar y Comunitaria, Departamento de Medicina Clínica, Universidad Miguel Hernández; Grupo de Trabajo de Diabetes de la semFyC, Alicante, España.
José Luis Torres BaileUnidad de investigación, Centro de salud Cabo Huertas; Grupo de Trabajo de Diabetes de la semFyC, San Juan (Alicante), España; Medicina Familiar y Comunitaria, Medicina Preventiva y Salud Pública, Centro de salud Rodríguez Paterna; Grupo de Trabajo de Diabetes de la semFyC, Logroño (La Rioja), España.
Patxi Ezkurra LoiolaMedicina Familiar y Comunitaria, Centro de salud Zumaia; Grupo de Trabajo de Diabetes de la semFyC, Zumaia (Guipúzcoa), España.
en representación del Grupo de Trabajo de Diabetes de la SemFyC
en representación del Grupo de Trabajo de Diabetes de la SemFyC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current circumstances cause by the COVID-19 force primary care doctors to find out new ways to guarantee the health care of our type 2 diabetes patients. There is evidence that supports the remote consultation efficacy in the glycemic control in patients with type 2 diabetes. Facing the rapid adaptation of clinical practice to the remote consultation use, from de Diabetes Group of the Spanish Society of Family and Community Medicine (SemFyC), we have prepared a document embodied in a telematic action / monitoring algorithm in the care of patients with type 2 diabetes.

Indexed as

AlgorithmsChecklistCombined Modality TherapyDiabetes Mellitus, Type 2Diet TherapyExercise TherapyHumansHypoglycemic AgentsMedication AdherenceRemote ConsultationHypoglycemic AgentsCOVID-19Diabetes mellitus tipo 2TelemedicinaTelemedicineType 2 diabetes

Identifiers

PMID33743202
PMCPMC7969144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.